Author Archives: Mark Manfredi

Kyn to Ikena: The Art and Science of Rebranding
December 17, 2019

This blog was written by Mark Manfredi, CEO of Ikena Oncology, and guest blogger Maude Tessier, CBO, as part of the From The Trenches feature of LifeSciVC. When we started to think about changing our company name, we knew it

Leave a comment

Early Company Evolution – People, Pipeline, and Purse
September 16, 2019

This blog was written by Mark Manfredi, CEO of Kyn Therapeutics, as part of the From The Trenches feature of LifeSciVC. “Time flies when you’re having fun.” That’s how I feel as I reflect on the first three years of

Leave a comment

Life After ECHO-301: Lessons Learned About Modulating IDO/TDO To Treat Cancer
April 12, 2018

This blog was written by Mark Manfredi, CEO of Kyn Therapeutics and former Atlas Entrepreneur-in-Residence, as part of the From The Trenches feature of LifeSciVC.  Last week we learned about the failure of the much anticipated ECHO-301/KEYNOTE-252 trial that studied

Leave a comment